Dr. Lynn T. Dengel, MD

Dr. Dengel practices at University of Virginia Physicians Group in Charlottesville, Virginia.

Dr. Dengel's NPI, 1134334592, was assigned on May 11, 2007. Dr. Dengel graduated from Georgetown University School of Medicine in 2005. Dr. Dengel holds Virginia license 0101254889.

Dr. Dengel's primary practice is University of Virginia Physicians Group, at 1204 W Main St, Charlottesville, VA 22903 in Charlottesville City. The practice phone is (434) 295-1000.

Dr. Dengel's primary practice is University of Virginia Physicians Group in Charlottesville, Virginia. Dr. Dengel is also affiliated with University Medical Center. The medical group on file is UVA Physicians Group. Dmand AI also links Dr. Dengel to 1 more hospital, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dengel practices, 4 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Dengel's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Dengel is licensed in Virginia.

CMS data shows 230 Medicare services from Dr. Dengel across 11 procedure codes in 2024, for 134 Medicare patients. Medicare paid $32,692 for them.

CMS counts 134 Medicare patients who saw Dr. Dengel in 2024. The largest group is 65 to 74, with 69 patients. 69% of them have high cholesterol, and 64% have high blood pressure. Their average risk score is 1.36, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dengel's median patient age at 64, with 82% women.

In 2024, Dr. Dengel wrote 12 Medicare Part D claims. 100% of them were for generic drugs. They cover 1 drug, with $93 in total drug cost. In 2016, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Dengel for performance year 2024, reported as part of a group. Dr. Dengel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dengel as offering telehealth. CMS counts 66 procedures of melanoma (skin cancer) excision by Dr. Dengel, more than 89% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 20 papers to Dr. Dengel, published from 2012 to 2024. 2012 was the busiest year, with 2. The most frequent topics are Melanoma, Skin Neoplasms and Lymph Nodes. Dr. Dengel has published most often in J Surg Res. Dr. Dengel's most frequent co-authors are Craig L. Slingluff, MD, Randy Jones, MD and Tari A. King, MD.

Dmand AI links Dr. Dengel to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Breast Neoplasms, Carcinoma, Merkel Cell and Breast Diseases.

CMS Open Payments shows 4 general payments to Dr. Dengel from 2 drug and device companies from 2016 to 2018. Food and beverage make up the largest share, 100% of the total. Medtronic USA, Inc. paid the most, $27.

Dr. Dengel graduated from Georgetown University School of Medicine in 2005.